| CODE |
101583 |
| COMPONENT |
EXTENDED-SPECTRUM BETA LACTAMASE BY CEFTAZIDIME TO CEFTAZIDIME+CLAVULANATE INHIBITORY CONCENTRATION RATIO |
| CHECK DIGIT |
3 |
| PROPERTY |
IMPRESSION/INTERPRETATION OF STUDY |
| DATE LAST CHANGED |
2023-08-15 00:00:00 |
| CHANGE TYPE |
ADD |
| TIME ASPECT |
POINT |
| SYSTEM |
BLD.POS GROWTH |
| SCALE TYPE |
Ordinal |
| METHOD TYPE |
BASED ON LAB DATA |
| CLASS |
ABXBACT |
| FULLY SPECIFIED NAME |
EXTENDED-SPECTRUM BETA LACTAMASE BY CEFTAZIDIME TO CEFTAZIDIME+CLAVULANATE INHIBITORY CONCENTRATION RATIO:IMP:PT:BLD.POS GROWTH:ORD:BASED ON LAB DATA |
| SHORTNAME |
ESBL CFT TO CFT-CLAV IC RTO BD POS IMP |
| LONG COMMON NAME |
ESBL BY CEFTAZIDIME TO CEFTAZIDIME-CLAVULANATE IC RATIO [INTERPRETATION] BY BASED ON LAB DATA IN POSITIVE BLOOD CULTURE QUALITATIVE |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
5371289 |
| EFFECTIVE DATE/TIME |
-
- 2023-12-20 00:00:00
- STATUS: ACTIVE
|
